sr 48692 has been researched along with mirtazapine in 1 studies
Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (mirtazapine) | Trials (mirtazapine) | Recent Studies (post-2010) (mirtazapine) |
---|---|---|---|---|---|
203 | 3 | 36 | 1,538 | 324 | 646 |
Protein | Taxonomy | sr 48692 (IC50) | mirtazapine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0851 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2239 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.2239 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.1995 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2239 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 3.1623 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2239 | |
Transporter | Rattus norvegicus (Norway rat) | 0.26 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Robertson, VB; Wilson, MS | 1 |
1 other study(ies) available for sr 48692 and mirtazapine
Article | Year |
---|---|
Neurotensin receptor agonists and antagonists for schizophrenia.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Data Interpretation, Statistical; Humans; Mianserin; Mirtazapine; Neurotensin; Peptide Fragments; Piperidines; Pyrazoles; Quinolines; Receptors, Neurotensin; Research Design; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |